Photocure is committed to serving all shareholders and potential investors by providing consistent, open and prompt disclosure of relevant information. Our policy is to handle all stakeholders, including the investor community and analysts, equally. By providing easy and timely access to the latest information, Photocure’s web pages can help ensure fair valuation of the company's shares.
Photocure Hosts Bladder Cancer Key Opinion Leader Breakfast in New York City
Photocure ASA hosted on August 25 an educational event in New York aimed at institutional investors and analysts, which focused on the treatment of bladder cancer.The Photocure sharePhotocure's shares were listed on the main list of the Oslo Stock Exchange in May 2000. The ticker symbol is PHO (Reuters: PHO.OL). The share capital of Photocure is 21,510,429 shares at NOK 0.50 each. Photocure has only one class of shares. Shareholder matter questions such as change of address, dividend payments and transfer of shares should be directed to your local account operator.
Photocure’s registrar is:
Nordea Bank Norge ASA, Issuer Services
Post office box 1166 Sentrum, 0107 Oslo
Telephone: +47 22 48 50 00/Fax: +47 22 48 63 49
DividendsPhotocure is focusing its resources on building a speciality pharma company and the Board will recommend payment of dividends in line with the company’s results and development.